Patent · US Active

sGC stimulators

US11207323B2 · kind B2 · utility

0Cited by
10References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 13, 2020
Grant dateDec 28, 2021
Priority date
Expiry dateMar 13, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formulae I′ and I are described, which are useful as stimulators of sGC, particularly NO-independent, heme-dependent stimulators. These compounds are also useful for treating, preventing or managing various disorders that are herein disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.